Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Pathology & Oncology Research
Published in: Pathology & Oncology Research 3/2001

01-09-2001 | Article

Significance of immunohistochemical c-ErbB-2 product localisation pattern for prognosis in human breast cancer

Authors: Syed Abdus Aziz, Shahid Pervez, Shaista Khan, Naila Kayani, Syed Igbal Azam, Mohammed Hussain Rahbar

Published in: Pathology & Oncology Research | Issue 3/2001

Login to get access
Metadata
Title
Significance of immunohistochemical c-ErbB-2 product localisation pattern for prognosis in human breast cancer
Authors
Syed Abdus Aziz
Shahid Pervez
Shaista Khan
Naila Kayani
Syed Igbal Azam
Mohammed Hussain Rahbar
Publication date
01-09-2001
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 3/2001
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/BF03032348

Other articles of this Issue 3/2001

Pathology & Oncology Research 3/2001 Go to the issue

Review

Telomerase: Biological function and potential role in cancer management

Article

Expression of erbB/HER receptors, heregulin and p38 in primary breast cancer using quantitative immunohistochemistry

Article

Effect of Earthworm (G-90) Extract on Formation and Lysis of Clots Originated from Venous Blood of Dogs with Cardiopathies and with Malignant Tumors

Article

Proliferating activity in differential diagnosis of benign phyllodes tumor and cellular fibroadenomas: Is it helpful?

Article

Vascularization pattern of c6 glioma is modified with medroxyprogesterone acetate and ibuprofen in Wistar rat brain

Article

Relationship between apoptosis regulator proteins (bcl-2 and p53) and Gleason score in prostate cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits